UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052288
Receipt number R000059691
Scientific Title Improving the accuracy of carbon-ion beam dose calculations using stopping power ratios estimated using dual energy CT
Date of disclosure of the study information 2023/10/02
Last modified on 2025/03/27 14:31:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Improving the accuracy of carbon-ion beam dose calculations using Dual Energy CT

Acronym

Improving the accuracy of carbon-ion beam dose calculations using Dual Energy CT

Scientific Title

Improving the accuracy of carbon-ion beam dose calculations using stopping power ratios estimated using dual energy CT

Scientific Title:Acronym

Improving the accuracy of carbon-ion beam dose calculations using stopping power ratios estimated using dual energy CT

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To perform DECT imaging at the same time as treatment planning CT imaging for patients undergoing carbon-ion radiotherapy, compare it with conventional methods, examine whether it is possible to reduce range error, and explore its superiority.

Basic objectives2

Others

Basic objectives -Others

Improving the accuracy of carbon-ion beam dose calculations

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Dose distribution calculated for Dual Energy CT and Single Energy CT images and dose to OAR and planning target volume in DVH analysis

Key secondary outcomes

Estimated range of each beam calculated for Dual Energy CT and Single Energy CT images and distribution of stopping power ratio for each tissue


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) head and neck cancer
2) Be over 20 years old.
3) Performance status (ECOG) is 0-1.
4) Written consent will be obtained from the research subject to participate in this research.

Key exclusion criteria

1) Patients in which metals other than metal markers for treatment have been placed in the body, affecting radiation calculations.
2) Patients that have been judged by a physician, such as a researcher, to be unsuitable for this study due to medical or other reasons.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name SHINOTO
Middle name
Last name MAKOTO

Organization

National Institutes for Quantum Science and Technology

Division name

QST hospital

Zip code

2638555

Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

0432063306

Email

shinoto.makoto@qst.go.jp


Public contact

Name of contact person

1st name SHINOTO
Middle name
Last name MAKOTO

Organization

National Institutes for Quantum Science and Technology

Division name

QST hospital

Zip code

2638555

Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

0432063306

Homepage URL


Email

shinoto.makoto@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Science and Technology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Science and Technology

Address

4-9-1 Anagawa, Inage-ku, Chiba

Tel

043-206-4706

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 07 Month 21 Day

Date of IRB

2023 Year 09 Month 01 Day

Anticipated trial start date

2023 Year 10 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2023 Year 09 Month 23 Day

Last modified on

2025 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059691